Home » Topics » Regulatory » Patents

Patents
RSS

Recent Aditech patent announces novel antipsoriatic agents

Feb. 12, 2007

Novel antiviral agents disclosed in recent patent from University of California, Oakland

Feb. 9, 2007

Novel treatments for musculoskeletal and connective tissue disorders claimed in recent patents

Feb. 9, 2007

New treatments for gastrointestinal disorders claimed in recent patent literature

Feb. 9, 2007

Recent Corus patent imparts novel therapeutic agents for chronic obstructive pulmonary disease

Feb. 9, 2007

Recent patents cover novel therapeutic agents for cardiovascular disorders

Feb. 8, 2007

Novel treatment options for hematological disorders disclosed in recent AstraZeneca and IRM patents

Feb. 8, 2007

New therapeutic agents for glaucoma disclosed in recent Aerie patent

Feb. 8, 2007

Recent patents impart new therapeutic agents for cancer

Feb. 7, 2007

Recent Isis and Louisiana State University patents report novel diagnostic agents

Feb. 7, 2007

Popular Stories

Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
Innervation can slow, as well as speed, tumor growth, study finds
BioWorld
Innervation by the sympathetic nervous system is typically a boon to tumors. But researchers from Weill Cornell Medicine and colleagues have shown that in some...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.